Expansion of human cord blood hematopoietic stem/progenitor cells in three-dimensional Nanoscaffold coated with Fibronectin

Allogeneic hematopoietic stem cell transplantation is used in the treatment of patients suffering from hematologic and non-hematologic disorders, but the application is limited by the identification of a suitable donor. Umbilical cord blood (UCB) is an alternative source of hematopoietic stem cell...

Full description

Bibliographic Details
Main Authors: Seyed Hadi Mousavi, Saeid Abroun, Masoud Soleimani, Seyed Javad Mowla
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2015-06-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/391
id doaj-b1795dbe218c466db6f99263347c8937
record_format Article
spelling doaj-b1795dbe218c466db6f99263347c89372020-11-25T04:00:16ZengTehran University of Medical SciencesInternational Journal of Hematology-Oncology and Stem Cell Research2008-22072015-06-0192377Expansion of human cord blood hematopoietic stem/progenitor cells in three-dimensional Nanoscaffold coated with FibronectinSeyed Hadi Mousavi0Saeid Abroun1Masoud Soleimani2Seyed Javad Mowla3PhD student of Hematology, Department of Hematology and Blood Banking, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.Associated Professor of Hematology, Department of Hematology and Blood Banking, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.Associated Professor of Hematology, Department of Hematology and Blood Banking, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.Associated Professor of Genetic, Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran. Allogeneic hematopoietic stem cell transplantation is used in the treatment of patients suffering from hematologic and non-hematologic disorders, but the application is limited by the identification of a suitable donor. Umbilical cord blood (UCB) is an alternative source of hematopoietic stem cell (HSC) transplantation. Despite all advantages, the limited cell dose is one of the  major obstacles. Ex-vivo expansion of HSC is an alternative way to overcome this problem.In this study, polycaprolactone (PCL) scaffold coated with fibronectin (3D) is compared to routine cell culture system (two dimensional, 2D) used for cell culture.1×10(4) cord blood CD34+ cells isolated by MACS were seeded on PCL scaffold and allowed to expand for 10  days. Before and after this period, total cells, CD34(+) cells, CFC assay and CXCR4 expression were evaluated.Our findings demonstrated that 3D scaffold produced a 58-fold expansion of total cells compared to 2D cultures (38-fold expansion). Also CD34+ cells in 3D compare to 2D cell culture was 40-fold and 2.66 fold increased, respectively; this difference was statistically significant (p<0.05). Moreover, total number of colonies in the 3D scaffold was higher than those of 2D cell culture system, but no statistically significant difference was observed. Higher expression of CXCR4 in 3D compared to 2D showed better homing of cells that were cultured in 3D scaffold (p<0.05).PCL scaffold coated with fibronectin had higher number of total cells and CD34+cells than 2D routine culture system. Findings revealed that 3D is a proper cell culture system for hematopoietic stem cell expansion, compared to 2D. https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/3913D cultureCord Blood Stem Cell TransplantationHematopoietic Stem CellsTissue Engineering
collection DOAJ
language English
format Article
sources DOAJ
author Seyed Hadi Mousavi
Saeid Abroun
Masoud Soleimani
Seyed Javad Mowla
spellingShingle Seyed Hadi Mousavi
Saeid Abroun
Masoud Soleimani
Seyed Javad Mowla
Expansion of human cord blood hematopoietic stem/progenitor cells in three-dimensional Nanoscaffold coated with Fibronectin
International Journal of Hematology-Oncology and Stem Cell Research
3D culture
Cord Blood Stem Cell Transplantation
Hematopoietic Stem Cells
Tissue Engineering
author_facet Seyed Hadi Mousavi
Saeid Abroun
Masoud Soleimani
Seyed Javad Mowla
author_sort Seyed Hadi Mousavi
title Expansion of human cord blood hematopoietic stem/progenitor cells in three-dimensional Nanoscaffold coated with Fibronectin
title_short Expansion of human cord blood hematopoietic stem/progenitor cells in three-dimensional Nanoscaffold coated with Fibronectin
title_full Expansion of human cord blood hematopoietic stem/progenitor cells in three-dimensional Nanoscaffold coated with Fibronectin
title_fullStr Expansion of human cord blood hematopoietic stem/progenitor cells in three-dimensional Nanoscaffold coated with Fibronectin
title_full_unstemmed Expansion of human cord blood hematopoietic stem/progenitor cells in three-dimensional Nanoscaffold coated with Fibronectin
title_sort expansion of human cord blood hematopoietic stem/progenitor cells in three-dimensional nanoscaffold coated with fibronectin
publisher Tehran University of Medical Sciences
series International Journal of Hematology-Oncology and Stem Cell Research
issn 2008-2207
publishDate 2015-06-01
description Allogeneic hematopoietic stem cell transplantation is used in the treatment of patients suffering from hematologic and non-hematologic disorders, but the application is limited by the identification of a suitable donor. Umbilical cord blood (UCB) is an alternative source of hematopoietic stem cell (HSC) transplantation. Despite all advantages, the limited cell dose is one of the  major obstacles. Ex-vivo expansion of HSC is an alternative way to overcome this problem.In this study, polycaprolactone (PCL) scaffold coated with fibronectin (3D) is compared to routine cell culture system (two dimensional, 2D) used for cell culture.1×10(4) cord blood CD34+ cells isolated by MACS were seeded on PCL scaffold and allowed to expand for 10  days. Before and after this period, total cells, CD34(+) cells, CFC assay and CXCR4 expression were evaluated.Our findings demonstrated that 3D scaffold produced a 58-fold expansion of total cells compared to 2D cultures (38-fold expansion). Also CD34+ cells in 3D compare to 2D cell culture was 40-fold and 2.66 fold increased, respectively; this difference was statistically significant (p<0.05). Moreover, total number of colonies in the 3D scaffold was higher than those of 2D cell culture system, but no statistically significant difference was observed. Higher expression of CXCR4 in 3D compared to 2D showed better homing of cells that were cultured in 3D scaffold (p<0.05).PCL scaffold coated with fibronectin had higher number of total cells and CD34+cells than 2D routine culture system. Findings revealed that 3D is a proper cell culture system for hematopoietic stem cell expansion, compared to 2D.
topic 3D culture
Cord Blood Stem Cell Transplantation
Hematopoietic Stem Cells
Tissue Engineering
url https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/391
work_keys_str_mv AT seyedhadimousavi expansionofhumancordbloodhematopoieticstemprogenitorcellsinthreedimensionalnanoscaffoldcoatedwithfibronectin
AT saeidabroun expansionofhumancordbloodhematopoieticstemprogenitorcellsinthreedimensionalnanoscaffoldcoatedwithfibronectin
AT masoudsoleimani expansionofhumancordbloodhematopoieticstemprogenitorcellsinthreedimensionalnanoscaffoldcoatedwithfibronectin
AT seyedjavadmowla expansionofhumancordbloodhematopoieticstemprogenitorcellsinthreedimensionalnanoscaffoldcoatedwithfibronectin
_version_ 1724451533991444480